mhurhangee/ep-ind-claims huggingface dataset:
Extraction unit employed in a system for the analysis of a liquid sample, comprising: - an extraction device comprising at least one zone for extraction of at least one analyte contained in the said liquid sample and a device for the gas-analysis of the said analytes; - the said extraction unit comprising three connection points, referred to as first connection point, second connection point and third connection point, such that: - the said first connection point is arranged in order to be joined to a first fluid inlet intended to receive an incoming liquid stream originating from the liquid sample, - the said second connection point is arranged in order to be joined to a second fluid inlet intended to be connected to a first sort of gas to be injected in order to inject an incoming gas stream (FG1, FG2), - the said third connection point is arranged in order to be joined to an analysis device; - the said extraction unit being characterized in that it comprises a main channel joining the said first connection point to the said second connection point through the said extraction device, a secondary channel connected to the main channel in order to directly join the third connection point to the said first connection point and to the said extraction device, and a fluid T-shaped section intended to bring about the joining of the secondary channel to the main channel, and in that - the said secondary channel exhibits a greater hydraulic resistance than that of the main channel. - an extraction device comprising at least one zone for extraction of at least one analyte contained in the said liquid sample and a device for the gas-analysis of the said analytes; - the said extraction unit comprising three connection points, referred to as first connection point, second connection point and third connection point, such that: - the said first connection point is arranged in order to be joined to a first fluid inlet intended to receive an incoming liquid stream originating from the liquid sample, - the said second connection point is arranged in order to be joined to a second fluid inlet intended to be connected to a first sort of gas to be injected in order to inject an incoming gas stream (FG1, FG2), - the said third connection point is arranged in order to be joined to an analysis device; - the said extraction unit being characterized in that it comprises a main channel joining the said first connection point to the said second connection point through the said extraction device, a secondary channel connected to the main channel in order to directly join the third connection point to the said first connection point and to the said extraction device, and a fluid T-shaped section intended to bring about the joining of the secondary channel to the main channel, and in that - the said secondary channel exhibits a greater hydraulic resistance than that of the main channel.
A gas turbine engine comprising: a turbine shaft; a compressor shaft coaxial with the turbine shaft, with one shaft surrounding the other; and a gear assembly coupling the turbine shaft to the compressor shaft and including an input gear mounted to the turbine shaft, an output 10 gear mounted to the compressor shaft, a pair of idler gear shafts, each said idler gear shaft having a first stage gear meshed with the input gear and configured to provide a first stage of speed change, each idler gear shaft having a second stage gear axially spaced from the first stage gear and rotating with the first stage gear, the second stage gear meshed with 15 the output gear and configured to provide a second stage of speed change, characterised in that the gas turbine engine further comprises landmarks (A1, A2, B1, B2) for aligning the gear assembly into a desired alignment orientation during assembly of the gear assembly, wherein the landmarks (A1, A2, B1, B2) are defined by an alignment marker (A1, A2) on each of the idler gear shafts, and corresponding alignment markers (B1, B2) on a structure of the gas turbine engine surrounding the idler gear shafts. a turbine shaft; a compressor shaft coaxial with the turbine shaft, with one shaft surrounding the other; and a gear assembly coupling the turbine shaft to the compressor shaft and including an input gear mounted to the turbine shaft, an output 10 gear mounted to the compressor shaft, a pair of idler gear shafts, each said idler gear shaft having a first stage gear meshed with the input gear and configured to provide a first stage of speed change, each idler gear shaft having a second stage gear axially spaced from the first stage gear and rotating with the first stage gear, the second stage gear meshed with 15 the output gear and configured to provide a second stage of speed change, characterised in that the gas turbine engine further comprises landmarks (A1, A2, B1, B2) for aligning the gear assembly into a desired alignment orientation during assembly of the gear assembly, wherein the landmarks (A1, A2, B1, B2) are defined by an alignment marker (A1, A2) on each of the idler gear shafts, and corresponding alignment markers (B1, B2) on a structure of the gas turbine engine surrounding the idler gear shafts.
A long-range ordered layered double hydroxide of formula [M II (1-x) M III x 2] x+ [A n- x/n] which is optionally hydrated and in which M II is a divalent metal cation or a mixture of two or more divalent metal cations, M III is a trivalent metal cation or a mixture of two or more trivalent metal cations, x is 1/3, and A is an interlayer anion having a charge n, wherein the metal cation ratio in the layered double hydroxide is of M II to M III of 2:1, wherein the layered double hydroxide either is (a) not a hybrid or (b) a hybrid in which some or all of the interlayer anion A is replaced by one or more biologically active agent and/or one or more antigen, said biologically active agent being selected from uric acid, ATP, AMP, GMP, cAMP, metal salts, oil in water emulsions, Toll like receptor agonists, saponins, iscoms, polyethyleneimine and combinations thereof, and wherein A is selected from conjugate bases of acids having a pKa of 1 or higher, except for in LDHs when M II comprises Ca 2+ wherein A is selected from conjugate bases of acids having a pKa of -4 or higher, for use in preventing or treating a medical condition selected from infectious diseases and proliferative diseases (including cancers). M II is a divalent metal cation or a mixture of two or more divalent metal cations, M III is a trivalent metal cation or a mixture of two or more trivalent metal cations, x is 1/3, and A is an interlayer anion having a charge n, wherein the metal cation ratio in the layered double hydroxide is of M II to M III of 2:1, wherein the layered double hydroxide either is (a) not a hybrid or (b) a hybrid in which some or all of the interlayer anion A is replaced by one or more biologically active agent and/or one or more antigen, said biologically active agent being selected from uric acid, ATP, AMP, GMP, cAMP, metal salts, oil in water emulsions, Toll like receptor agonists, saponins, iscoms, polyethyleneimine and combinations thereof, and wherein A is selected from conjugate bases of acids having a pKa of 1 or higher, except for in LDHs when M II comprises Ca 2+ wherein A is selected from conjugate bases of acids having a pKa of -4 or higher, for use in preventing or treating a medical condition selected from infectious diseases and proliferative diseases (including cancers). wherein the metal cation ratio in the layered double hydroxide is of M II to M III of 2:1, wherein the layered double hydroxide either is (a) not a hybrid or (b) a hybrid in which some or all of the interlayer anion A is replaced by one or more biologically active agent and/or one or more antigen, said biologically active agent being selected from uric acid, ATP, AMP, GMP, cAMP, metal salts, oil in water emulsions, Toll like receptor agonists, saponins, iscoms, polyethyleneimine and combinations thereof, and wherein A is selected from conjugate bases of acids having a pKa of 1 or higher, except for in LDHs when M II comprises Ca 2+ wherein A is selected from conjugate bases of acids having a pKa of -4 or higher, for use in preventing or treating a medical condition selected from infectious diseases and proliferative diseases (including cancers).
A panel arrangement for dividing the interior space of a container wherein a panel is provided with an attachment device adapted to affix the panel in relation to said container, characterized by at least one opening (23, 25, 27) in the panel; and the attachment device comprising: a first part located at one side of the panel and a second part located on the other side of the panel, at least one of which has a connector for attaching the panel arrangement to said container; and at least one member (35, 37, 39, 41) reaching through the at least one opening; wherein a play is provided between the edges of the opening and said at least one member, such that the attachment device can be moved in relation to the panel in at least one direction in which the plane of the panel extends. the attachment device comprising: a first part located at one side of the panel and a second part located on the other side of the panel, at least one of which has a connector for attaching the panel arrangement to said container; and at least one member (35, 37, 39, 41) reaching through the at least one opening; a first part located at one side of the panel and a second part located on the other side of the panel, at least one of which has a connector for attaching the panel arrangement to said container; and at least one member (35, 37, 39, 41) reaching through the at least one opening; wherein a play is provided between the edges of the opening and said at least one member, such that the attachment device can be moved in relation to the panel in at least one direction in which the plane of the panel extends.
A method for micrositing a wind farm having a plurality of wind turbines via a loads optimization function, the method comprising: (a) determining one or more wind directions with or without turbine shadow for each of the wind turbines in the wind farm; (b) determining at least one additional wind parameter for each of the wind directions; (c) calculating, via simulation using a loads optimization loop that can rerun the loads optimization function one or more times, loads for each of the wind turbines in the wind farm based on the identified wind directions with or without turbine shadow for each of the wind turbines in the wind farm and the at least one additional wind parameter for each of the wind directions, wherein the loads optimization function corresponds to equation ∑ i = cut in cut out Number of Hours i ( Wind Speed i + TI i Wind Speed i 2, where TI is a turbulence intensity, Number of Hours is a number of hours of operation of the wind turbines at different wind directions, Cut In is a cut in wind speed, and Cut Out is a cut out wind speed; and (d) determining a site layout for the wind farm based on the calculated loads. (a) determining one or more wind directions with or without turbine shadow for each of the wind turbines in the wind farm; (b) determining at least one additional wind parameter for each of the wind directions; (c) calculating, via simulation using a loads optimization loop that can rerun the loads optimization function one or more times, loads for each of the wind turbines in the wind farm based on the identified wind directions with or without turbine shadow for each of the wind turbines in the wind farm and the at least one additional wind parameter for each of the wind directions, wherein the loads optimization function corresponds to equation ∑ i = cut in cut out Number of Hours i ( Wind Speed i + TI i Wind Speed i 2, where TI is a turbulence intensity, Number of Hours is a number of hours of operation of the wind turbines at different wind directions, Cut In is a cut in wind speed, and Cut Out is a cut out wind speed; and (d) determining a site layout for the wind farm based on the calculated loads.
A guidance template device for providing guidance for a targeted tissue treatment or tissue removal procedure, the guidance template device comprising: a cover portion shaped and sized to fit over a surface of a patient near a target tissue to undergo a treatment or removal procedure, the cover portion including at least one form (106a, 106b) including a patient-specific interior surface customized based on images obtained during pre-procedure imaging to match the surface of the patient such that the cover portion correspondingly fits over the surface of the patient and maintains the surface of the patient in a desired position; at least one access site integrally formed with the cover portion and positioned so as to direct a working end of a first medical device to a location associated with the target tissue when the cover portion is placed on the surface of the patient, the position of the at least one access site with respect to the target tissue having been determined based on the pre-procedure images; characterised by at least one imaging jig integrally formed with the cover portion and configured to retain an in-procedure imaging device therein and further configured to control positioning and/or movement of the in-procedure imaging device relative to the location associated with the target tissue when the cover portion is placed on the surface of the patient. a cover portion shaped and sized to fit over a surface of a patient near a target tissue to undergo a treatment or removal procedure, the cover portion including at least one form (106a, 106b) including a patient-specific interior surface customized based on images obtained during pre-procedure imaging to match the surface of the patient such that the cover portion correspondingly fits over the surface of the patient and maintains the surface of the patient in a desired position; at least one access site integrally formed with the cover portion and positioned so as to direct a working end of a first medical device to a location associated with the target tissue when the cover portion is placed on the surface of the patient, the position of the at least one access site with respect to the target tissue having been determined based on the pre-procedure images; characterised by at least one imaging jig integrally formed with the cover portion and configured to retain an in-procedure imaging device therein and further configured to control positioning and/or movement of the in-procedure imaging device relative to the location associated with the target tissue when the cover portion is placed on the surface of the patient.
An authentication method comprising: sending a mapping extension indicator and a certificate from a first computing device to a second computing device, the mapping extension indicator indicating that the first computing device can send a mapping extension containing mapping information to the second computing device to aid the second computing device in mapping the certificate to an account or an authentication server; determining by the second computing device whether the second computing device supports the mapping information, and if so, acknowledging from the second computing device to the first computing device that the second computing device can accept mapping information pursuant to the received mapping extension indicator; sending the mapping information from the first computing device to the second computing device; and locating by the second computing device the account or the authentication server based on the sent mapping information and the certificate. sending a mapping extension indicator and a certificate from a first computing device to a second computing device, the mapping extension indicator indicating that the first computing device can send a mapping extension containing mapping information to the second computing device to aid the second computing device in mapping the certificate to an account or an authentication server; determining by the second computing device whether the second computing device supports the mapping information, and if so, acknowledging from the second computing device to the first computing device that the second computing device can accept mapping information pursuant to the received mapping extension indicator; sending the mapping information from the first computing device to the second computing device; and locating by the second computing device the account or the authentication server based on the sent mapping information and the certificate.
A gripper (10, 90, 98, 120) for holding a wind turbine blade when the wind turbine blade is being moved, comprising: a lower blade holding structure configured to engage an underside of the wind turbine blade; an upper blade holding structure configured to engage an upper side of the wind turbine blade; and a force transfer mechanism operatively coupled to at least one of the lower or upper blade holding structures (14, 16), characterised in that the force transfer mechanism is configured to increase the force applied between the lower blade holding structure and the underside of the wind turbine blade and/or between the upper blade holding structure and the upper side of the wind turbine blade when the wind turbine blade is accelerated during movement along a central longitudinal axis of the wind turbine blade. a lower blade holding structure configured to engage an underside of the wind turbine blade; an upper blade holding structure configured to engage an upper side of the wind turbine blade; and a force transfer mechanism operatively coupled to at least one of the lower or upper blade holding structures (14, 16), characterised in that the force transfer mechanism is configured to increase the force applied between the lower blade holding structure and the underside of the wind turbine blade and/or between the upper blade holding structure and the upper side of the wind turbine blade when the wind turbine blade is accelerated during movement along a central longitudinal axis of the wind turbine blade.
A method of applying a personal care composition to a portion of the skin to form a treated surface, said composition comprising: a) from 0.001% to 8%, preferably from 0.1% to 3% by weight of a multi-active system comprising: i) at least 5% to 50% by weight of said multi-active system of an extract of camellia sinensis; ii) at least 15% to 80% by weight of said multi-active system of panthenol; and iii) at least 5% to 50% by weight of said multi active system of glycyrrhizinate salt; and b) from 50% to 99.99% of a carrier, and further comprising a step of at least partially removing hair from said at least a portion of the treated surface. a) from 0.001% to 8%, preferably from 0.1% to 3% by weight of a multi-active system comprising: i) at least 5% to 50% by weight of said multi-active system of an extract of camellia sinensis; ii) at least 15% to 80% by weight of said multi-active system of panthenol; and iii) at least 5% to 50% by weight of said multi active system of glycyrrhizinate salt; and i) at least 5% to 50% by weight of said multi-active system of an extract of camellia sinensis; ii) at least 15% to 80% by weight of said multi-active system of panthenol; and iii) at least 5% to 50% by weight of said multi active system of glycyrrhizinate salt; and b) from 50% to 99.99% of a carrier, and further comprising a step of at least partially removing hair from said at least a portion of the treated surface.
A method for immobilizing nucleic acids on a support, comprising the steps of: (a) providing a nucleic acid with a stretch of nucleotides of only one basetype, wherein said stretch of nucleotides of only one basetype is located at least at the 3' or 5' terminus of said nucleic acid; and (b) immobilizing said nucleic acid on a solid support by crosslinking by light, wherein said crosslinking by light is performed at a wavelength of about 300-500 nm, preferably at a wavelength of 365 nm, wherein said stretch of nucleotides of only one basetype has a length from about 7 to about 100 nucleotides, and said crosslinking is performed using an amount of energy ranging from about 0.5 Joule/cm 2 to about 10 Joule/cm 2. (a) providing a nucleic acid with a stretch of nucleotides of only one basetype, wherein said stretch of nucleotides of only one basetype is located at least at the 3' or 5' terminus of said nucleic acid; and (b) immobilizing said nucleic acid on a solid support by crosslinking by light, wherein said crosslinking by light is performed at a wavelength of about 300-500 nm, preferably at a wavelength of 365 nm, wherein said stretch of nucleotides of only one basetype has a length from about 7 to about 100 nucleotides, and said crosslinking is performed using an amount of energy ranging from about 0.5 Joule/cm 2 to about 10 Joule/cm 2.
A method for communicating in an unlicensed band, the method comprising: transmitting, by a transmission, TX, node, a preemption signal for preempting at least one communication node to start communication to a target reception, RX, node in the unlicensed band; the method being characterized in that if the TX node receives a ready signal from the target RX node and the TX node does not receive a hold signal from the at least one communication node, transmitting, by the TX node, a data signal to the target RX node in the unlicensed band, wherein the preemption signal is transmitted by using a narrow beam having substantially the same width and direction as the data signal. transmitting, by a transmission, TX, node, a preemption signal for preempting at least one communication node to start communication to a target reception, RX, node in the unlicensed band; the method being characterized in that if the TX node receives a ready signal from the target RX node and the TX node does not receive a hold signal from the at least one communication node, transmitting, by the TX node, a data signal to the target RX node in the unlicensed band, wherein the preemption signal is transmitted by using a narrow beam having substantially the same width and direction as the data signal.